Covetrus, Inc. (CVET)

2 members of Congress have disclosed 10 trades in Covetrus, Inc. (CVET) via STOCK Act filings. The most recent disclosure was a sale by Josh Gottheimer on 15 September 2022. The most active traders have been Josh Gottheimer (7) and Gilbert Cisneros (3). Aggregate disclosed activity totals roughly $56K in purchases and $24K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for CVET
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for CVET

5 transactions
Compliance: 100%
Josh Gottheimer15 Sept 202216 Oct 2022SaleStock$1,001 - $15,000N/A
Josh Gottheimer18 Oct 202115 Nov 2021PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer15 Sept 202113 Oct 2021SaleStock$1,001 - $15,000N/A
Gilbert Cisneros23 Dec 202011 Jan 2021PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer16 Oct 20205 Nov 2020PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$0

Volume

5.3M

Beta

1.51

P/E Ratio

-69.97

Fundamentals

EPS

$-0.30

Div. Yield

-

Open

$20.93

Day Range

$20.93 – $21.00

Company Information

Sector
Healthcare
Industry
Medical - Distribution
Exchange
NASDAQ · USD
Country
US
CEO
Benjamin Wolin
IPO Date
2019-02-04

Covetrus, Inc. functions as a technology and services provider for the animal health sector. The company supplies a comprehensive range of animal health consumables, including its own branded and proprietary items, along with diverse equipment (small...

Earnings

Recent Quarters

Q3 20222 Nov
EPS-
Q2 20224 Aug
EPS$0.25
Beat 0.0%
Q1 20225 May
EPS$0.25
Beat 13.6%
Q4 202124 Feb
EPS$0.26
Beat 4.0%
Q3 20214 Nov
EPS$0.23
Beat 0.0%
Q2 20215 Aug
EPS$0.26
Beat 8.3%
Q1 20216 May
EPS$0.21
Beat 23.5%
Q4 20201 Mar
EPS$0.21
Beat 31.3%
Q3 202010 Nov
EPS$0.26
Beat 44.4%
Q2 202011 Aug
EPS$0.27
Beat 237.5%
Q1 202014 May
EPS$0.18
Beat 50.0%
Q4 20193 Mar
EPS$0.18
Beat 50.0%
Q3 201912 Nov
EPS$0.17
Beat 142.9%
Q2 201913 Aug
EPS$0.13
Miss 18.8%
Q1 201915 May
EPS$0.13
Miss 23.5%
Q4 20187 Feb
EPS$0.30
Q2 201830 Sept
EPS$0.14
Q1 201830 Jun
EPS$0.26
Q4 201731 Mar
EPS$0.21
Q3 201731 Dec
EPS$0.01

2 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CVET

Which members of Congress have traded CVET?
2 members of Congress have disclosed 10 trades in Covetrus, Inc. (CVET) under the STOCK Act. The most active traders are Josh Gottheimer and Gilbert Cisneros.
When was CVET most recently disclosed by Congress?
The most recent CVET disclosure was a sale by Josh Gottheimer on 15 September 2022.
What is the total disclosed congressional trading volume for CVET?
Members of Congress have disclosed approximately $56K in CVET purchases and $24K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CVET?
This CVET page updates as soon as new STOCK Act disclosures are filed for Covetrus, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.